NanoPro 1000 System from ProteinSimple

Description

The NanoPro 1000 system enables rapid, quantitative analysis of specific proteins in as few as 25 cells per assay. Detailed information is generated on the post-translational modification status of critical signaling proteins. The system is fully automated and speeds samples from a standard 384-well microplate to final results, ensuring exceptional sample-to-sample consistency.
  • Detailed Specifications
  • ItemNanoPro 1000 System
  • CompanyProteinSimple
  • PriceGet QuoteGet Quote for this Product
  • Catalog Number004-109
  • Dimensions(WxDxH) 94 x 61 x 84 cm (37 x 24 x 33 inches)
  • ApplicationsProtein Analysis / Quantify Phosphoprotein Signaling / Identify Phosphoprotein Isoforms
  • Voltage100 – 230 Volts
ProteinSimple
ProteinSimple
3040 Oakmead Village Dr
Santa Clara, California 95051
United States
Phone: 888.607.9692 (US only)
408.510.5500
408.510.5599
  • NanoPro™ Assay: Asparagine Synthetase (ASNS)

    The enzyme-drug, L-asparaginase, has been used since the 1970s to treat acute lymphoblastic leukemia. Asparagine synthetase (ASNS) expression has been found to be correlated with L-asparaginase efficacy in leukemia cell lines, in leukemia primary tumor samples, and more recently, in cancer cell lines from other tissues of origin. Silencing ASNS expression by RNAi has indicated the L-asparaginase/ASNS relationship is causal and suggests that ASNS expression may be useful as a predictive clinical biomarker of L-asparaginase efficacy. ASNS presents as a single peak in the NanoPro assay. Expected changes of expression are observed upon siRNA as well as L-asparaginase treatment. Read More
  • NanoPro™ Assay: Lactate Dehydrogenase (LDH)

    Lactate dehydrogenase (LDH) is a reversible enzyme that catalyzes the reduction of pyruvate to lactate or the oxidation of lactate to pyruvate. In most human cells, LDH in its native form is a tetramer with 5 possible isoforms (LDH1-5), combinations of LDHA (calculated pI: 8.4) and/or LDHB (calculated pI: 5.7). LDH overexpression and differential expression of LDH isoforms have been implicated in the pathogenesis and progression of many cancers. Read More
  • NanoPro™ Assay: 4E-BP1

    Translation repressor protein 4E-BP inhibits cap-dependent translation by binding to the eIF4E translation initiation factor. Hyperphosphorylation of 4E-BP disrupts this interaction and results in activation of cap-dependent translation. Both the PI3 kinase/Akt pathway and FRAP/mTOR kinase regulate 4E-BP activity. 4E-BP1 has been implicated as a biomarker for several cancer types, while 4E-BP2 has been shown to potentially play a role in energy homeostasis. We show 4E-BP1 activation in MCF10A cells in response to EGF using total and anti-phospho 4E-BP1 antibodies that enable distinction between phospho and non-phospho peaks. Read More
  • NanoPro™ Assay: 4E-BP2

    Translation repressor protein 4E-BP inhibits cap-dependent translation by binding to the eIF4E translation initiation factor. Hyperphosphorylation of 4E-BP disrupts this interaction and results in activation of cap-dependent translation. Both the PI3 kinase/AKT pathway and FRAP/mTOR kinase regulate 4E-BP activity. 4E-BP1 has been implicated as a biomarker for several cancer types, while 4E-BP2 has been shown to potentially play a role in energy homeostasis. We show 4E-BP2 activation in MCF10A cells in response to EGF and 4E-BP2 inhibition in MCF7 cells with LY294002 (PI3 kinase inhibitor). Read More
  • NanoPro™ Assay: Crk-L

    Crk-like protein (Crk-L) is an adapter protein and phosphotyrosine-containing substrate implicated in transformation by the bcr-abl oncogene and in signaling by cytokines. It has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. Crk-L is a substrate of the BCR-ABL tyrosine kinase and plays a role in fibroblast transformation by BCR-ABL. We show that Crk-L phosphorylation is reduced in response to Imatinib (commonly known as Gleevec®) treatment in K562 cells. Read More
  • NanoPro™ Assay: c-Myc Epitope Tag on EGFP

    Epitope tags are widely used for afinity purification as well as for highly sensitive detection of recombinant proteins. The c-Myc-tag consists of a short peptide sequence (MEEQKLISEEDLLM). EGFP was expressed with a c-Myc-tag at either the C- or N-terminus of the protein. As expected from the amino acid composition of this tag, a slight acidic shift in the pI of the tagged protein can be observed. Read More
  • NanoPro™ Assay: FLAG Epitope Tag on EGFP

    Epitope tags are widely used for afinity purification as well as for highly sensitive detection of recombinant proteins. The FLAG-tag consists of a short peptide sequence (MADYKDDDDKM). EGFP was expressed with a FLAG-tag at either the C- or N-terminus of the protein. As expected from the amino acid composition of this tag, a slight acidic shift in the pI of the tagged protein can be observed. Read More
  • NanoPro™ Assay: HA Epitope Tag on EGFP

    Epitope tags are widely used for afinity purification as well as for highly sensitive detection of recombinant proteins. The HA-tag consists of a short peptide sequence (MAYPYDVPDYASM). Here, EGFP was expressed with a HA-tag at both the C- and N-terminal of the protein. As expected from the amino acid composition of this tag, a slight acidic shift in the pI of the tagged protein can be observed. Read More
  • NanoPro™ Assay: MEK1

    Dual specificity mitogen-activated protein kinases (MEK) are members of the dual specificity protein kinase family, which act upstream from the classical MAP kinases through phosphorylation and thus activation of ERK1 and 2 in response to a wide variety of extra- and intracellular signals. While the functions of MEK1 and MEK2 are very similar, these kinases differ significantly in the way they are regulated. For example, serum addition can specifically induce MEK1 activity in CHO cells. By contrast, MEK2 appears to be the functionally predominant isoform in formyl-methionyl-leucyl-phenylalanine treated neutrophils. Here we show MEK1 activation in MCF10A cells treated with EGF. Read More
  • NanoPro™ Assay: MEK2

    Dual specificity mitogen-activated protein kinases (MEK) are members of the dual specificity protein kinase family, which act upstream from the classical MAP kinases through phosphorylation and thus activation of ERK1 and 2 in response to a wide variety of extra- and intracellular signals. While the functions of MEK1 and MEK2 are very similar, theses kinases differ significantly in the way they are regulated. For example, serum addition can specifically induce MEK1 activity in CHO cells. By contrast, MEK2 appears to be the functionally predominant isoform in formyl-methionyl-leucyl-phenylalanine treated neutrophils. Here we show MEK2 activation in MCF10A cells in response to EGF stimulation. Read More